Universitätsklinikum Essen

Re: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer (2024) Klümper N, Vera-Badillo FE, Eckstein M, Hadaschik B, Grünwald V Journal article Guidelines for Neuroprognostication in Critically Ill Adults with Moderate–Severe Traumatic Brain Injury (2024) Muehlschlegel S, Rajajee V, Wartenberg KE, Alexander SA, Busl KM, Creutzfeldt CJ, Fontaine GV, et al. Journal article Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. (2024) Fuchs M, Jacob AS, Kaul H, Kobe C, Kuhnert G, Pabst T, Greil R, et al. Journal article Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment (2024) Overbeek KA, Poulsen JL, Lanzillotta M, Vinge-Holmquist O, Macinga P, Demirci AF, Sindhunata DP, et al. Journal article Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics (2024) Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, et al. Journal article Prehospital management of chest injuries in severely injured patients—a systematic review and clinical practice guideline update (2024) Waydhas C, Prediger B, Kamp O, Kleber C, Nohl A, Schulz-Drost S, Schreyer C, et al. Journal article, Review article Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning (2024) Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, et al. Journal article Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression (2024) Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, et al. Journal article S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion (2024) Groß S, Bitzer M, Albert J, Blödt S, Boda-Heggemann J, Brunner T, Caspari R, et al. Journal article Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells - The DETECT III Clinical Trial (2024) Fehm T, Mueller V, Banys-Paluchowski M, Fasching P, Friedl TW, Hartkopf A, Huober J, et al. Journal article